Show simple item record

dc.contributor.authorWorld Health Organization, Regional Office for South-East Asia
dc.coverage.spatialNew Delhien_US
dc.date.accessioned2016-04-11T11:20:30Z
dc.date.available2016-04-11T11:20:30Z
dc.date.issued2012
dc.identifier.govdocSEA-CD-245
dc.identifier.urihttp://www.who.int/iris/handle/10665/205057
dc.description.abstractLymphatic filariasis (‎LF)‎ is endemic in 9 of the 11 Member States of the South-East Asia Region of the World Health Organization. Mass Drug Administration (‎MDA)‎ has been implemented to achieve elimination of LF in the Region. In 2001, Sri Lanka initiated MDA in eight LF-endemic districts covering a population of 11 million, and stopped MDA in 2007 after completing five rounds. The microfilarial rate was well below 1%. Post-MDA surveillance including vector surveillance has been introduced. As per the recommendations of the Regional Programme Review Group for Elimination of Lymphatic Filariasis, a WHO expert mission visited Sri Lanka in 2011 and initiated the process of verification of LF elimination. In line with the LF Transmission Assessment Survey Manual of WHO 2011, the team visited two endemic districts and tested 244 schoolchildren of 6-7 years of age with ICT cards for antigenaemia. All were found to be negative indicating that there was no transmission. The expert team recommended continuation of ICT testing of the selected sample, and preparation of the dossier as part of the process of verification.en_US
dc.language.isoenen_US
dc.publisherWHO Regional Office for South-East Asiaen_US
dc.subjectLYMPHATIC FILARIASISen_US
dc.titleExpert mission to Sri Lanka for verification of elimination of lymphatic filariasis : Report of the mission, 12-18 June 2011en_US
dc.typeMeeting reportsen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record